本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aura Biosciences, Inc.

5.71
+0.14002.51%
盤前5.70-0.0100-0.18%06:26 EDT
成交量:12.39萬
成交額:70.47萬
市值:2.87億
市盈率:-3.26
高:5.86
開:5.61
低:5.53
收:5.57
資料載入中...
2025/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities